Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$64,042,128
+$29,766,357 QoQ
Shares Held
254,499
+61.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#332
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $2,100,933,315 across 14 Drug Manufacturers - General names. ABBV ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
694,293 | $832,755,921 | |
| 2 | AZN |
Astrazeneca PLC
|
2,332,566 | $442,301,164 | |
| 3 | JNJ |
Johnson & Johnson
|
1,364,685 | $346,589,048 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,843,591 | $236,901,443 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
254,499 | $64,042,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,063,855 | $61,299,324 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
284,948 | $36,000,330 | |
| 8 | NVO |
Novo Nordisk A S
|
657,641 | $31,527,309 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,042,128 | 254,499 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $34,275,771 | 157,597 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,658,090 | 64,152 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,010,927 | 56,193 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,507,696 | 61,996 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,647,806 | 50,820 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,517,064 | 115,459 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $27,958,033 | 141,574 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $47,551,689 | 277,237 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $80,235,262 | 440,611 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $75,667,201 | 488,270 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $29,073,853 | 195,048 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,471,786 | 99,991 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $10,128,441 | 63,553 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,521,457 | 65,104 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $8,110,040 | 60,428 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,915,351 | 90,855 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $9,495,916 | 58,577 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,177,818 | 67,783 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $7,251,559 | 67,225 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,992,708 | 70,958 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $10,400,698 | 96,107 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $90,436,957 | 844,022 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $74,654,182 | 852,314 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $73,501,180 | 748,637 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $51,200,136 | 672,006 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||